Conexeu Sciences INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Jeffrey Sharpe has increased his beneficial ownership in Conexeu Sciences Inc. to 5.4% following the vesting of performance warrants tied to market capitalization milestones.